Advances with microRNAs in Parkinson's disease research
L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug design, development …, 2013 - Taylor & Francis
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
MicroRNAs play a role in Parkinson's disease by regulating microglia function: from pathogenetic involvement to therapeutic potential
S Li, G Bi, S Han, R Huang - Frontiers in Molecular Neuroscience, 2022 - frontiersin.org
Parkinson's disease (PD) is a clinically common neurodegenerative disease of the central
nervous system (CNS) characterized by loss of dopamine neurons in the substantia nigra …
nervous system (CNS) characterized by loss of dopamine neurons in the substantia nigra …
MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease
Parkinson's disease (PD) is a multifactorial neurodegenerative condition with symptoms
such as resting tremor, rigidity, bradykinesia (slowness of moment), and postural instability …
such as resting tremor, rigidity, bradykinesia (slowness of moment), and postural instability …
microRNAs in Parkinson's disease: from pathogenesis to novel diagnostic and therapeutic approaches
L Leggio, S Vivarelli, F L'Episcopo, C Tirolo… - International journal of …, 2017 - mdpi.com
Parkinson's disease (PD) is the most prevalent central nervous system (CNS) movement
disorder and the second most common neurodegenerative disease overall. PD is …
disorder and the second most common neurodegenerative disease overall. PD is …
MicroRNA dysregulation in Parkinson's disease: a narrative review
Parkinson's disease (PD) is a severely debilitating neurodegenerative disease, affecting the
motor system, leading to resting tremor, cogwheel rigidity, bradykinesia, walking and gait …
motor system, leading to resting tremor, cogwheel rigidity, bradykinesia, walking and gait …
Role of MicroRNAs in Parkinson's disease
SY Goh, YX Chao, ST Dheen, EK Tan… - International journal of …, 2019 - mdpi.com
Parkinson's disease (PD) is a disabling neurodegenerative disease that manifests with
resting tremor, bradykinesia, rigidity and postural instability. Since the discovery of …
resting tremor, bradykinesia, rigidity and postural instability. Since the discovery of …
MiRNAs and neural stem cells: a team to treat Parkinson's disease?
T Palm, L Bahnassawy, J Schwamborn - RNA biology, 2012 - Taylor & Francis
Parkinson's disease (PD) is a common neurodegenerative disorder with no proven
neuroprotective or neurorestorative therapies. During disease progression, degeneration of …
neuroprotective or neurorestorative therapies. During disease progression, degeneration of …
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease
Parkinson's disease (PD) is a debilitating neurological disorder characterized by the
impairment of the motor system, resulting in symptoms such as resting tremor, cogwheel …
impairment of the motor system, resulting in symptoms such as resting tremor, cogwheel …
Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease
J Lu, Y Xu, Z Quan, Z Chen, Z Sun, H Qing - Neuroscience, 2017 - Elsevier
Parkinson's disease is a debilitating neurodegenerative movement disorder, characterized
by the progressive and selective loss of dopaminergic neurons located in the substantia …
by the progressive and selective loss of dopaminergic neurons located in the substantia …
RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis
SM Heman-Ackah, M Hallegger, MS Rao… - Frontiers in molecular …, 2013 - frontiersin.org
Parkinson's disease (PD) is a debilitating neurodegenerative disease characterized
primarily by the selective death of dopaminergic (DA) neurons in the substantia nigra pars …
primarily by the selective death of dopaminergic (DA) neurons in the substantia nigra pars …